Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients.
Saved in:
| Title: | Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients. |
|---|---|
| Authors: | Sanders JA; Department of Bioinformatics & Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.; Bioinformatics Services Division, University of North Carolina at Charlotte, Kannapolis, NC, USA., Frasier C; Department of Bioinformatics & Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.; Bioinformatics Services Division, University of North Carolina at Charlotte, Kannapolis, NC, USA., Matulay JT; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Steuerwald NM; Molecular Biology and Microarray Core Facilities, Atrium Health, Charlotte, NC, USA., Zhu J; Department of Medical Oncology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Grigg CM; Department of Medical Oncology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Kearns JT; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Riggs SB; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Gaston KE; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Brouwer CR; Department of Bioinformatics & Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.; Bioinformatics Services Division, University of North Carolina at Charlotte, Kannapolis, NC, USA., Burks RT; Carolinas Pathology, Charlotte, NC, USA., Hartman AL; Carolinas Pathology, Charlotte, NC, USA., Foureau DM; Immune Monitoring Core Laboratory, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Burgess EF; Department of Medical Oncology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Clark PE; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. |
| Source: | Translational andrology and urology [Transl Androl Urol] 2021 Jul; Vol. 10 (7), pp. 2998-3009. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AME Pub Country of Publication: China NLM ID: 101581119 Publication Model: Print Cited Medium: Print ISSN: 2223-4691 (Print) Linking ISSN: 22234683 NLM ISO Abbreviation: Transl Androl Urol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34430403 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sanders+JA%22">Sanders JA</searchLink>; Department of Bioinformatics & Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.; Bioinformatics Services Division, University of North Carolina at Charlotte, Kannapolis, NC, USA.<br /><searchLink fieldCode="AU" term="%22Frasier+C%22">Frasier C</searchLink>; Department of Bioinformatics & Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.; Bioinformatics Services Division, University of North Carolina at Charlotte, Kannapolis, NC, USA.<br /><searchLink fieldCode="AU" term="%22Matulay+JT%22">Matulay JT</searchLink>; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Steuerwald+NM%22">Steuerwald NM</searchLink>; Molecular Biology and Microarray Core Facilities, Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+J%22">Zhu J</searchLink>; Department of Medical Oncology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Grigg+CM%22">Grigg CM</searchLink>; Department of Medical Oncology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kearns+JT%22">Kearns JT</searchLink>; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Riggs+SB%22">Riggs SB</searchLink>; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gaston+KE%22">Gaston KE</searchLink>; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Brouwer+CR%22">Brouwer CR</searchLink>; Department of Bioinformatics & Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.; Bioinformatics Services Division, University of North Carolina at Charlotte, Kannapolis, NC, USA.<br /><searchLink fieldCode="AU" term="%22Burks+RT%22">Burks RT</searchLink>; Carolinas Pathology, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hartman+AL%22">Hartman AL</searchLink>; Carolinas Pathology, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Foureau+DM%22">Foureau DM</searchLink>; Immune Monitoring Core Laboratory, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Burgess+EF%22">Burgess EF</searchLink>; Department of Medical Oncology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Clark+PE%22">Clark PE</searchLink>; Department of Urology, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101581119%22">Translational andrology and urology</searchLink> [Transl Androl Urol] 2021 Jul; Vol. 10 (7), pp. 2998-3009. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Pub%22">AME Pub </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101581119 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>2223-4691 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222234683%22">22234683 </searchLink><i>NLM ISO Abbreviation: </i>Transl Androl Urol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34430403 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21037/tau-21-158 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2998 Titles: – TitleFull: Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sanders JA – PersonEntity: Name: NameFull: Frasier C – PersonEntity: Name: NameFull: Matulay JT – PersonEntity: Name: NameFull: Steuerwald NM – PersonEntity: Name: NameFull: Zhu J – PersonEntity: Name: NameFull: Grigg CM – PersonEntity: Name: NameFull: Kearns JT – PersonEntity: Name: NameFull: Riggs SB – PersonEntity: Name: NameFull: Gaston KE – PersonEntity: Name: NameFull: Brouwer CR – PersonEntity: Name: NameFull: Burks RT – PersonEntity: Name: NameFull: Hartman AL – PersonEntity: Name: NameFull: Foureau DM – PersonEntity: Name: NameFull: Burgess EF – PersonEntity: Name: NameFull: Clark PE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2021 Jul Type: published Y: 2021 Identifiers: – Type: issn-print Value: 2223-4691 Numbering: – Type: volume Value: 10 – Type: issue Value: 7 Titles: – TitleFull: Translational andrology and urology Type: main |
| ResultId | 1 |